Optimizing the use of alkylators in neuro-oncology
Perry, J R
- Publisher: American Society of Clinical Oncology
Clinic for Neurology | 610 Medicine & health
For more than three decades, alkylating agents have been the most widely used class of chemotherapeutic agents for the treatment of glial brain tumors. Today, concomitant and adjuvant temozolomide is the standard of care for newly diagnosed glioblastoma. Temozolomide al...